dysmenorrhea
Conditions
Interventions
administration period is two months dose: 2.5g/time , 7.5g/day
Sponsors
Keio University School
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: The person who consults the obstetrics and gynecology department outpatient of Keio University Hospital and the associated facilities The person who is aware of menstrual pain The person whom a doctor gave a diagnosis of dysmenorrhea A menstrual cycle is the following for 38 days more than 25 days The person who gets an agreement of the participation in examination in a document
Exclusion criteria
Exclusion criteria: The person having a gynecologic disorder to need emergency The person who enforces hormone treatment The patient who has the serious disease and unstable organ disorders such as the malignant tumors except the gynecologic disorder The person with a history of the internal use of the Kampo medicine preparation within the past two months The person who has an allergy to Kampo medicine The person with a remarkable digestive organ symptom The person who participated in a clinical trial since a study start within the past three months The person who judged that the chief physician was inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect to the menstrual colic of the patient in two months after Kampo medicine internal use | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of the adverse event | — |
Countries
Japan
Contacts
Public ContactYuko Horiba
Keio University School of medicine Center for Kampo Medicine
Outcome results
None listed